LeidosLDOS
LDOS
0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
66% more first-time investments, than exits
New positions opened: 151 | Existing positions closed: 91
19% more repeat investments, than reductions
Existing positions increased: 306 | Existing positions reduced: 258
5% more funds holding
Funds holding: 771 [Q3] → 813 (+42) [Q4]
0.33% less ownership
Funds ownership: 74.13% [Q3] → 73.8% (-0.33%) [Q4]
12% less capital invested
Capital invested by funds: $16.3B [Q3] → $14.4B (-$1.9B) [Q4]
35% less call options, than puts
Call options by funds: $71.8M | Put options by funds: $110M
36% less funds holding in top 10
Funds holding in top 10: 11 [Q3] → 7 (-4) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$155
7%
upside
Avg. target
$161
11%
upside
High target
$173
19%
upside
3 analyst ratings
2 positive
67%
1 neutral
33%
0 negative
0%
Truist Securities Tobey Sommer 30% 1-year accuracy 17 / 56 met price target | 7%upside $155 | Buy Maintained | 14 Apr 2025 |
Wells Fargo Matthew Akers 53% 1-year accuracy 41 / 78 met price target | 19%upside $173 | Overweight Maintained | 8 Apr 2025 |
UBS Gavin Parsons 55% 1-year accuracy 12 / 22 met price target | 7%upside $156 | Neutral Maintained | 12 Feb 2025 |
Financial journalist opinion
Based on 25 articles about LDOS published over the past 30 days
Positive
Zacks Investment Research
1 day ago
Why Leidos (LDOS) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Neutral
PRNewsWire
6 days ago
Leidos invests $10 million in AI disease detection with University of Pittsburgh
RESTON, Va. , April 18, 2025 /PRNewswire/ -- Leidos (NYSE: LDOS) is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE).

Positive
Zacks Investment Research
6 days ago
Here is What to Know Beyond Why Leidos Holdings, Inc. (LDOS) is a Trending Stock
Leidos (LDOS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Positive
Zacks Investment Research
1 week ago
Here's Why Leidos (LDOS) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Positive
Zacks Investment Research
1 week ago
Wall Street Bulls Look Optimistic About Leidos (LDOS): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Neutral
Seeking Alpha
1 week ago
Leidos: A Defense Company To Consider
Leidos Holdings, Inc. operates in defense, IT security, data analytics, and healthcare, recently realigning into four segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Leidos has shown strong performance, boasting a 450% total return over the past decade, exceeding returns of the overall market. The company has been growing its dividend for a few years, but I think they could offer investors higher increases.

Positive
CNBC Television
1 week ago
Trade Tracker: Steve Weiss buys Netflix, Meta, Taiwan Semi, Nvidia, Leidos and Goldman Sachs
Steve Weiss, founder and managing partner at Short Hills Capital Partners, joins CNBC's "Halftime Report" to detail his latest buys despite his bearish market outlook.

Positive
Zacks Investment Research
1 week ago
LDOS or HWM: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Aerospace - Defense sector might want to consider either Leidos (LDOS) or Howmet (HWM). But which of these two companies is the best option for those looking for undervalued stocks?

Positive
Zacks Investment Research
2 weeks ago
Why Leidos (LDOS) is Poised to Beat Earnings Estimates Again
Leidos (LDOS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Positive
Market Watch
2 weeks ago
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have led to seesaw intraday action.

Charts implemented using Lightweight Charts™